An Arizona doctor’s perspective on Theranos
Theranos is dealing with more push-back as its finger-stick blood-testing method gets put on hold at Walgreens locations before the FDA gives a final OK.
Watch out, Theranos? Edico Genome CEO backing stealth one-drop-of-blood startup
It looks like stealth startup SalveoDx is developing technology in the single drop of blood diagnostics space - a field dominated by Theranos to date. The company just raised $2 million.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
FDA makes it easier for Theranos to conduct testing outside of certified labs
Palo Alto super-startup Theranos got the OK from the FDA for its HSV-1 test to be performed outside of CLIA-certified labs - an important cog in its marketing strategy.
Theranos gets first FDA clearance, emerges from secrecy
Theranos, the secretive Palo Alto diagnostics company, just received regulatory approval for its HSV-1 test - a sign that perhaps it'll start chasing further approvals.